ARX:ASX
Aroa Biosurgery Ltd
0,48 AU$
arrow_downward
−1,02%(−0,0050) 1 p
20. nov, 16:10:08 GMT +11 · AUD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ARX põhistatistika genereerimine…
Ava
0,50 AU$
Kõrge
0,50 AU$
Madal
0,48 AU$
Turu kapit.
167,76 mln
Keskm. maht
259,42 tuh
Maht
192,34 tuh
Hinna ja tulu suhe
46,19
52 näd kõrgeim
0,78 AU$
52 näd madalaim
0,46 AU$
Aktsiatulu
0,01 AU$
Käibivad aktsiad
345,90 mln
Töötajate arv
261
Ava
0,50 AU$
Kõrge
0,50 AU$
Madal
0,48 AU$
Turu kapit.
167,76 mln
Keskm. maht
259,42 tuh
Maht
192,34 tuh
Hinna ja tulu suhe
46,19
52 näd kõrgeim
0,78 AU$
52 näd madalaim
0,46 AU$
Aktsiatulu
0,01 AU$
Käibivad aktsiad
345,90 mln
Töötajate arv
261
Uudised
Veebiallikatest ja uudistepartneritelt
WHEC.com
·
Vähem kui minut tagasi
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year as rout in tech stocks tanks the market
WSJ
·
11 tunni eest
S&P 500 Flirts With Correction
Los Angeles Times
·
3 tunni eest
S&P 500 falls 10% from record, entering correction as AI trade unravels
24/7 Wall St.
·
2 tunni eest
These 4 Conservative Dow Jones Industrials Dividend Stocks Are Built for Sell-Offs
Profiil
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Teave üksuse Aroa Biosurgery Ltd kohta